Pharmaceutical Benefits Scheme - new and amended listings and Medicare Benefits Schedule – new and amended listings
This 2014-15 budget measure has amended some existing listings for the Pharmaceutical Benefits Scheme (PBS) and added one new item. The PBS gives Australian residents and eligible overseas visitors access to affordable medicines.
Description of the measure
This measure has amended some existing listings for the Pharmaceutical Benefits Scheme (PBS) and added one new item. The PBS gives Australian residents and eligible overseas visitors access to affordable medicines. The changes include:
- ferric carboxymaltose – new listing from 1 June 2014 for the treatment of iron deficiency anaemia
- everolimus – amended listing from 1 June 2014 for the treatment of HER2 negative advanced breast cancer after failure of treatment with letrazole or anastrazole
- botulinum toxin type A – amended listing for the treatment of Urinary Incontinence Idiopathic Overactive Bladder.
Questions and answers
Who will be affected by this measure?
Eligible Australian residents and overseas visitors will be able to access these medicines under the PBS if prescribed by their health professional. Health professionals including pharmacists, general practitioners, specialists and nurse practitioners will need to be aware of these changes.
Am I eligible for this measure?
The Schedule of Pharmaceutical Benefits has been updated to show the new and amended listings. Health professionals will decide if their patient is eligible. Some of these medicines will require patients to meet particular restriction criteria listed in the Schedule of Pharmaceutical Benefits.
When will this measure start and finish?
Ferric carboxymaltose and everolimus will be listed from 1 June 2014. This is an ongoing measure.